FDA to expedite development of two Sanofi rare disease drugsThe FDA has agreed to expedite development of two rare disease drugs from Sanofi. The most significant of Share XFDA to expedite development of two Sanofi rare disease drugshttps://pharmaphorum.com/news/fda-to-expedite-development-of-two-sanofi-rare-disease/
Thanks Mr President, but you’re wrong about FDA, says rare disease groupNORD patient advocacy group responds to Congress speech Share XThanks Mr President, but you’re wrong about FDA, says rare disease grouphttps://pharmaphorum.com/news/thanks-mr-president-youre-wrong-fda-says-rare-disease-group/